EUVIMEDEUVIMED entdecken
Crossref

N-Glycan MALDI MSI Differentiates Kidney Glomerular Disease Phenotypes

Aaron O Angerstein iD, Vishwajeeth Pasham, Caroline Kittrell, Shana M Coley iD, Tamara K Nowling, Richard R Drake

Journal of the American Society for Mass Spectrometry · 05.08.2026 · 37 (8) · 1952-1963

DOI: 10.1021/jasms.6c00163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, online erschienen am 22.07.2026. Verfasst von Aaron O Angerstein und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Immunology, Medical University of South Carolina, 173 Ashley Ave, Charleston, South Carolina29425, United States. Hauptthemen laut MEDLINE: Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Polysaccharides, Kidney Glomerulus, Diabetic Nephropathies. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Office of the Assistant Secretary of Defense for Health Affairs, NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lupus nephritis (LN) and diabetic nephropathy (DN) are leading causes of kidney failure, characterized by distinct yet overlapping patterns of glomerular injury. While histopathology remains central to diagnosis, it provides limited insight into the underlying molecular remodeling. Here, we applied matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to define the spatial N-glycan landscape across human kidney biopsies from healthy controls (HCs) and patients with DN or LN. Whole-biopsy analyses demonstrated that identical N-glycan species adopt distinct spatial distributions depending on the disease context. Healthy kidneys were enriched in bisected N-glycans, DN in biantennary and sialylated species, and LN in fucosylated and paucimannose N-glycans, reflecting divergent enzymatic and pathogenic pathways. Glomerulus-resolved analyses substantially enhanced discrimination among disease groups, revealing previously undetected differences and highlighting disease-specific molecular phenotypes that were masked at the whole biopsy level. Notably, glomeruli classified as histologically normal exhibited distinct N-glycan signatures across disease states, indicating that molecular remodeling occurs independently of the overt structural changes. Within biopsies, N-glycan class composition shifted systematically with glomerular injury, with DN displaying more uniform remodeling and LN demonstrating greater phenotypic heterogeneity. Mixed-effect modeling confirmed significant morphology-dependent differences while accounting for biopsy-level clustering. MALDI-IHC analysis further supported phenotype-specific molecular differences across the glomerular subtypes. Collectively, these findings establish glomerular N-glycan architecture as a major driver of glycomic divergence across kidney diseases and position spatial N-glycomics as a translational approach for defining disease-specific molecular signatures within intact renal tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationPolysaccharidesKidney GlomerulusDiabetic NephropathiesHumansPhenotypeFemaleMale

Substanzen

Polysaccharides

Autor:innen und Institutionen

  • Department of Pharmacology and Immunology, Medical University of South Carolina, 173 Ashley Ave, Charleston, South Carolina29425, United States.
  • Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina29425, United States.
  • Arkana Laboratories, 10810 Executive Center Dr. Suite 100, Little Rock, Arkansas72211, United States.
  • NYU Langone Health, 550 first Avenue, Suite 461, New York, New York10016, United States.
  • Division of Rheumatology Department of Medicine, Medical University of South Carolina, 171 Ashley Avenue, Charleston, South Carolina29425, United States.

ORCID-Profile: Aaron O Angerstein, Shana M Coley

Förderung

  • Office of the Assistant Secretary of Defense for Health Affairs
  • NCI NIH HHS
  • NIDDK NIH HHS
  • SmartState Centers of Economic Excellence
  • NIH HHS
  • National Cancer Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Angerstein, A. O., Pasham, V., Kittrell, C., Coley, S. M., Nowling, T. K., & Drake, R. R. (2026). N-Glycan MALDI MSI Differentiates Kidney Glomerular Disease Phenotypes. Journal of the American Society for Mass Spectrometry, 37(8), 1952-1963. https://doi.org/10.1021/jasms.6c00163

Vancouver

Angerstein AO, Pasham V, Kittrell C, Coley SM, Nowling TK, Drake RR. N-Glycan MALDI MSI Differentiates Kidney Glomerular Disease Phenotypes. Journal of the American Society for Mass Spectrometry. 2026;37(8):1952-1963. doi:10.1021/jasms.6c00163

BibTeX
@article{Angerstein2026,
  author = {Angerstein, Aaron O and Pasham, Vishwajeeth and Kittrell, Caroline and Coley, Shana M and Nowling, Tamara K and Drake, Richard R},
  title = {N-Glycan MALDI MSI Differentiates Kidney Glomerular Disease Phenotypes},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2026},
  volume = {37},
  number = {8},
  pages = {1952--1963},
  doi = {10.1021/jasms.6c00163}
}
Kostenlos starten →